July 24, 2025

Michael Platten Appointed “Ambassador” of European Research Council

Michael Platten Appointed “Ambassador” of European Research Council

The scientist from Heidelberg University is to boost trust in the funding of innovative research

Prof. Dr Michael Platten has been appointed “Ambassador for the ERC” in order to engage with the public and decision-makers about the importance of groundbreaking research and its benefit for society and industry. The neurologist is one of two scientists in Germany selected for this ambassador network by the European Research Council (ERC) and the Association of ERC Grantees (AERG). A total of 32 outstanding researchers funded with an ERC Grant have been appointed ambassadors. Michael Platten, holder of a professorship at the Medical Faculty Mannheim of Heidelberg University, works at Mannheim University Hospital and the German Cancer Research Center (DKFZ).

Porträt Michael Platten
Michael Platten | © Medizinische Fakultät Mannheim der Universität Heidelberg

In his function as ERC ambassador in Germany, Prof. Platten is mandated to contribute to communicating the value of basic research to political decision-makers, the media, and the public. This includes highlighting the contribution it makes in dealing with societal, economic, environmental and political challenges. Another key concern is to boost trust in funding for innovative research. At the same time, the scientist is a contact partner for European Research Council grantees and he is expected to inform talented researchers about the financial opportunities offered by the ERC. The office of ambassador is initially for one year and can be extended up to six times.

Michael Platten is the director of the Department of Neurology at Mannheim University Hospital and director of the Mannheim Center for Translational Neuroscience, located at the Medical Faculty Mannheim of Heidelberg University. In addition, he heads the Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology at the German Cancer Research Center. In 2024 he received an ERC Advanced Grant, which funds groundbreaking research projects. In the framework of his ERC project at the DKFZ, Prof. Platten and his team are working on developing and optimizing personalized cell-based, AI-controlled immunotherapies for malignant brain tumors.

The European Research Council is an institution established by the European Commission to finance frontier research – groundbreaking, visionary research that crosses classical borders. The Association of ERC Grantees is an international organization with a current membership of approx. 10,000 ERC grantees past and present. The ERC and AERG hope to expand the “Ambassadors for the ERC” network in the future to more European Union member states and associated countries.

Our latest News

discover more
AlphaFold Database adds viral protein complexes to support pandemic preparedness

AlphaFold Database adds viral protein complexes to support pandemic preparedness

by Sera Guli The latest release includes protein structure predictions for thousands of viruses, which could improve the response to future outbreaks AI-predicted protein complex structures for over 2,800 viruses are now openly available in the AlphaFold Database. To better understand and protect against emerging pathogens, the dataset prioritises proteomes from viral families known to […]

European Commission grants €57 million to critical open data resources

European Commission grants €57 million to critical open data resources

Horizon Europe funding will support GENCODE, UniProt, and Europe PMC The European Commission has announced €57 million in funding to support GENCODE, UniProt, and Europe PMC. These life sciences data resources are delivered and managed by EMBL’s European Bioinformatics Institute (EMBL-EBI) alongside international partners. The financial support will be given in the shape of three […]

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies. The […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp